GlassScriptPhysician profile
Caty Milano
NPI 1336866433
$1,157.96
in general payments reported to CMS, 2019-2025
13 companies · $593 in 2025
The $593 reported for 2025 was more than what 89% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $258 · 2024: $307 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.96 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $288.11 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $142.38 | 2025 | |
| Sage Therapeutics, LLC | $116.80 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $113.15 | 2025 | |
| Sumitomo Pharma America, INC. | $106.06 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $92.88 | 2023-2025 | |
| Organon LLC | $81.17 | 2023-2025 | Nexplanon |
| Evofem Biosciences, INC. | $66.87 | 2023-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $66.11 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $37.46 | 2024-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $17.00 | 2024 | Aptima |
| Abbvie INC. | $15.12 | 2025 | |
| Pfizer INC. | $14.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caty Milano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.